scispace - formally typeset
D

Do Young Kim

Researcher at Yonsei University

Publications -  737
Citations -  18320

Do Young Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 58, co-authored 674 publications receiving 15091 citations. Previous affiliations of Do Young Kim include University of Ulsan & Fred Hutchinson Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis

TL;DR: In this article , the authors evaluated the predictive performance of pre-existing well-validated hepatocellular carcinoma (HCC) prediction models, established in patients with HBV-related cirrhosis who started potent antiviral therapy (AVT).
Journal ArticleDOI

Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea

TL;DR: In this paper, the status of hepatitis C virus (HCV) screening, confirmation, and treatment rates in a tertiary academic medical center in Korea was evaluated using a retrospective study, where the testing and positivity rates for anti-HCV antibodies and HCV RNA were sequentially analyzed.
Journal ArticleDOI

Increased Serum Antibody Titer against HPV-16 Antigen in Patients with Behçet's Disease.

TL;DR: Whether anti-HPV immunoglobulin G (IgG) antibody titer is increased in Behçet's disease (BD) is evaluated to determine whether HPV itself may be a possible extrinsic triggering infectious agent causing the development of BD.
Journal ArticleDOI

Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation

TL;DR: Serum potassium was an independent predictor of RA development in patients with HBV-related cirrhosis who were hospitalized to control ascitic decompensation, and Child-Pugh class and RA type were independent predictors for survival.
Journal ArticleDOI

Immunogenicity and protective efficacy of clade 2.3.2.1c and clade 2.3.4.4c H5Nx avian influenza antigen bank vaccines in mice, Korea.

TL;DR: The immunogenicity and protective efficacy of inactivated clade 2.3.2.1c (rgKA435) and H5Nx vaccines, which are representatives of an avian influenza antigen bank in Korea, were examined in mice, conferred 100% protection, with no morbidity, no severe body weight loss, and no virus replication in any of the tissues tested.